These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14515273)

  • 1. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.
    Sano H; Nagai K; Tsutsumi H; Kuroki Y
    Eur J Immunol; 2003 Oct; 33(10):2894-902. PubMed ID: 14515273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.
    Ghildyal R; Hartley C; Varrasso A; Meanger J; Voelker DR; Anders EM; Mills J
    J Infect Dis; 1999 Dec; 180(6):2009-13. PubMed ID: 10558959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages.
    Barr FE; Pedigo H; Johnson TR; Shepherd VL
    Am J Respir Cell Mol Biol; 2000 Nov; 23(5):586-92. PubMed ID: 11062136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.
    Löfgren J; Rämet M; Renko M; Marttila R; Hallman M
    J Infect Dis; 2002 Feb; 185(3):283-9. PubMed ID: 11807709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells.
    Hickling TP; Malhotra R; Bright H; McDowell W; Blair ED; Sim RB
    Viral Immunol; 2000; 13(1):125-35. PubMed ID: 10733174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R; Connor A; Gias E; Toms GL
    J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus and pulmonary surfactant.
    Griese M
    Viral Immunol; 2002; 15(2):357-63. PubMed ID: 12081017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
    Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
    Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
    Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
    Harcourt JL; Karron RA; Tripp RA
    J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
    Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
    Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8 mRNA synthesis and protein secretion are continuously up-regulated by respiratory syncytial virus persistently infected cells.
    Tirado R; Ortega A; Sarmiento RE; Gómez B
    Cell Immunol; 2005 Jan; 233(1):61-71. PubMed ID: 15936741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
    Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
    J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells.
    Arnold R; König B; Werchau H; König W
    Virology; 2004 Dec; 330(2):384-97. PubMed ID: 15567433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV.
    Watson A; Kronqvist N; Spalluto CM; Griffiths M; Staples KJ; Wilkinson T; Holmskov U; Sorensen GL; Rising A; Johansson J; Madsen J; Clark H
    Immunobiology; 2017 Feb; 222(2):111-118. PubMed ID: 27793398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
    Ayukawa H; Matsubara T; Kaneko M; Hasegawa M; Ichiyama T; Furukawa S
    Clin Exp Immunol; 2004 Jul; 137(1):151-5. PubMed ID: 15196256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.